Deposit Agreement Dated as of [DATE] , 2007Deposit Agreement • January 19th, 2007 • 3SBio Inc. • New York
DEPOSIT AGREEMENT dated as of [DATE] , 2007 (the “Deposit Agreement”) among 3SBIO INC. and its successors (the “Company”), JPMORGAN CHASE BANK, N.A., as depositary hereunder (the “Depositary”), and all holders from time to time of American Depositary Receipts issued hereunder (“ADRs”) evidencing American Depositary Shares (“ADSs”) representing deposited Shares (defined below). The Company hereby appoints the Depositary as depositary for the Deposited Securities and hereby authorizes and directs the Depositary to act in accordance with the terms set forth in this Deposit Agreement. All capitalized terms used herein have the meanings ascribed to them in Section 1 or elsewhere in this Deposit Agreement. The parties hereto agree as follows:
Agreement Regarding Transfer of Equity Interest In Shenyang Sunshine Pharmaceutical Co., Ltd.Interest Transfer Agreement • January 19th, 2007 • 3SBio Inc.
Agreement Regarding Transfer of Equity Interest In Shenyang Sunshine Pharmaceutical Co., Ltd.Equity Interest Transfer Agreement • January 19th, 2007 • 3SBio Inc.
EMPLOYMENT AND CONFIDENTIALITY AGREEMENTEmployment and Confidentiality Agreement • January 19th, 2007 • 3SBio Inc.
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into effective as of [•], 2006, (the “Effective Date”), by and between 3Sbio, Inc. (the “Company”), and [•], an individual residing in [•] (the “Employee”).
Purchase Agreement for Acquisition of Equity Interest In Liaoning Sunshine Bio- Pharmaceutical Company Limited Between Shenyang Sunshine Pharmaceutical Company Limited And Dan LouPurchase Agreement • January 19th, 2007 • 3SBio Inc.
REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN***. Agreement between Shenyang Sunshine Pharmaceutical Company and Epitomics, Inc. License and Co- development of anti-TNFalpha monoclonal antibody therapeutics3SBio Inc. • January 19th, 2007 • California
This term sheet is between Shenyang Sunshine Pharmaceutical Co. Ltd (Sunshine) and Epitomics Inc. (Epitomics). This document is to describe a developing and anticipated ongoing formal Licensing and Co-development relationship between the two companies in the field of commercializing anti-TNFalpha monoclonal antibodies to be used as therapeutic agents.
National Agency Agreement for Tietai3SBio Inc. • January 19th, 2007
In accordance with the relevant Chinese laws and regulations, Chengdu Borui Pharmaceutical Technology and Development Co., Ltd (hereinafter referred to as Party A) and Liaoning Sunshine Pharmaceutical Co., Ltd (hereinafter referred to as Party B), for the purpose of taking full advantages of each party and exploiting more market opportunities, have reached this agreement on the basis of mutual benefits and common development through friendly negotiations of both parties.
VOTING RIGHTS AGREEMENTVoting Rights Agreement • January 19th, 2007 • 3SBio Inc.
Purchase AgreementPurchase Agreement • January 19th, 2007 • 3SBio Inc.
The Equity Transfer Agreement Regarding Beijing Sunshine Bio-product Sales Company Limited Entered Into Between Shenyang Sunshine Pharmaceutical Company Limited and Dongmei SuEquity Transfer Agreement • January 19th, 2007 • 3SBio Inc.
The Equity Transfer Agreement Regarding Liaoning Sunshine Bio-Pharmaceutical Company Limited Between Shenyang Sunshine Pharmaceutical Company Limited And Dan LouEquity Transfer Agreement • January 19th, 2007 • 3SBio Inc.
Sole Agency Agreement for Baolijin3SBio Inc. • January 19th, 2007
Chengdu Institute of Biological Products (hereinafter referred to as “Party A”) and Liaoning Sunshine Pharmaceutical Co., Ltd. (hereinafter referred to as “Party B”) have entered into this Agreement on the basis of the principles of mutual benefits and joint development pursuant to the relevant Chinese laws and regulations and upon friendly negotiations between the two parties, for the purpose of making full use of their respective advantages and further expanding the market.
PURCHASE CONTRACT3SBio Inc. • January 19th, 2007
VOTING AGREEMENTVoting Agreement • January 19th, 2007 • 3SBio Inc.
This VOTING AGREEMENT (the “Agreement”) is entered into as of , 2006 by and among 3SBio Inc., a Cayman Island corporation (the “Company”) and the entities listed on Exhibit A hereto (the “Holders”).
Liaoning Sunshine Pharmaceutical Co., Ltd. Sales (Distribution) Agreement 20063SBio Inc. • January 19th, 2007
In accordance with the relevant Chinese laws and regulations, Party A and Party B have reached this agreement regarding sales (distribution) of Party A’s products by Party B on the basis of mutual benefits and common development through friendly negotiations of both parties.
Guarantee Agreement3SBio Inc. • January 19th, 2007
WHEREAS, Party A desires to provide guarantee security in favor of Party B with the purpose to ensure due performance of the debtor’s obligations under the Loan Agreement with the Reference No. 2006Shenhezi0006, entered into on February 20, 2006 by and between China Communications Materials Northeastern Co., Ltd., and Party B hereto (the “Master Agreement”);
Business Cooperation AgreementBusiness Cooperation Agreement • January 19th, 2007 • 3SBio Inc.
THIS BUSINESS COOPERATION AGREEMENT (hereinafter the “THIS AGREEMENT”) is entered into between the following parties on January 1, 2007 in Shanyang City, Liaoning Province:
EQUITY PLEDGE AGREEMENTEquity Pledge Agreement • January 19th, 2007 • 3SBio Inc.
In witness thereof, through friendly negotiations, Party A (hereinafter referred to as the “Pledgee”) and Party B (hereinafter referred to as the “Pledgor”) hereby agree as follows:
